Related Experiment Video

Updated: Jul 20, 2026

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

SP600125, a selective JNK inhibitor, aggravates hepatic ischemia-reperfusion injury

Kyung-Hoon Lee1, Sang-Eun Kim, Yun-Song Lee

  • 1Department of Molecular and Cellular Biology, Sungkyunkwan University School of Medicine, Suwon 440-746, Korea.

Experimental & Molecular Medicine
|September 6, 2006
PubMed

Insights

JNK inhibition using SP600125 unexpectedly worsened liver injury in a mouse model, increasing inflammation and tissue damage. These findings caution against using JNK inhibitors for hepatic ischemia-reperfusion injury.

Area of Science:

  • Hepatology
  • Immunology
  • Pharmacology

Background:

  • c-Jun N-terminal kinase (JNK) activation is observed during hepatic reperfusion.
  • JNK inhibitors have shown protective effects in ischemia-reperfusion (I/R) injury in other organs.

Purpose of the Study:

  • To investigate the effect of SP600125, a JNK inhibitor, on hepatic I/R injury in a mouse model.
  • To evaluate the impact of JNK inhibition on liver damage and inflammatory responses.

Main Methods:

  • A partial ischemia model was used in mice.
  • Mice were treated with SP600125 or a vehicle control.
  • Serum ALT levels, parenchymal destruction, leukocyte infiltration, tissue myeloperoxidase, malondialdehyde, and chemokine expression were assessed post-reperfusion.

Main Results:

  • SP600125 treatment led to increased serum ALT levels and more severe parenchymal destruction compared to vehicle control.
  • Higher levels of tissue myeloperoxidase, malondialdehyde, and chemokine expression were observed in the SP600125-treated group.
  • These results contradict previous findings suggesting a protective role for JNK inhibitors.

Conclusions:

  • JNK inhibition with SP600125 appears detrimental in hepatic I/R injury.
  • Caution is advised when considering JNK inhibitors for therapeutic use in hepatic I/R injury.
  • The role of JNK inhibition in modulating inflammatory infiltration requires careful consideration.

More Related Videos

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model09:22

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

Published on: April 2, 2017

Use of a Hanging-weight System for Liver Ischemia in Mice05:53

Use of a Hanging-weight System for Liver Ischemia in Mice

Published on: August 7, 2012

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...